Michael Hecht Olsen
Researcher Next ID · RN-038881
Researcher · Medicine
Charlottenlund, Denmark
- Works count
- 478
- Citation count
- 17,392
- H-index
- 60
- i10-index
- 211
Research interests
Publications
Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk
Circulation · 2020 · https://doi.org/10.1161/circulationaha.120.046361
Lancet Commission on Hypertension group position statement on the global improvement of accuracy standards for devices that measure blood pressure
Journal of Hypertension · 2019 · https://doi.org/10.1097/hjh.0000000000002246
Hypertension and cardiac arrhythmias: a consensus document from the European Heart Rhythm Association (EHRA) and ESC Council on Hypertension, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE)
EP Europace · 2017 · https://doi.org/10.1093/europace/eux091
Enhanced Predictive Capability of a 1-Hour Oral Glucose Tolerance Test: A Prospective Population-Based Cohort Study
Diabetes Care · 2017 · https://doi.org/10.2337/dc17-1351
Effectiveness of a lifestyle intervention led by female community health volunteers versus usual care in blood pressure reduction (COBIN): an open-label, cluster-randomised trial
The Lancet Global Health · 2017 · https://doi.org/10.1016/s2214-109x(17)30411-4
Estimated carotid–femoral pulse wave velocity has similar predictive value as measured carotid–femoral pulse wave velocity
Journal of Hypertension · 2016 · https://doi.org/10.1097/hjh.0000000000000935
Natriuretic peptides and integrated risk assessment for cardiovascular disease: an individual-participant-data meta-analysis
The Lancet Diabetes & Endocrinology · 2016 · https://doi.org/10.1016/s2213-8587(16)30196-6
A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the Lancet Commission on hypertension
The Lancet · 2016 · https://doi.org/10.1016/s0140-6736(16)31134-5
Impact of Age and Gender on the Prevalence and Prognostic Importance of the Metabolic Syndrome and Its Components in Europeans. The MORGAM Prospective Cohort Project
PLoS ONE · 2014 · https://doi.org/10.1371/journal.pone.0107294
Cardiovascular risk prediction in the general population with use of suPAR, CRP, and Framingham Risk Score
International Journal of Cardiology · 2012 · https://doi.org/10.1016/j.ijcard.2012.07.018
Stroke mortality and trends from 1990 to 2006 in 39 countries from Europe and Central Asia: implications for control of high blood pressure
European Heart Journal · 2011 · https://doi.org/10.1093/eurheartj/ehr045
Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population
Journal of Internal Medicine · 2010 · https://doi.org/10.1111/j.1365-2796.2010.02252.x
Risk prediction is improved by adding markers of subclinical organ damage to SCORE
European Heart Journal · 2009 · https://doi.org/10.1093/eurheartj/ehp546
Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document
Blood Pressure · 2009 · https://doi.org/10.3109/08037050903450468
Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document
Journal of Hypertension · 2009 · https://doi.org/10.1097/hjh.0b013e328333146d
N-terminal pro-brain natriuretic peptide, but not high sensitivity C-reactive protein, improves cardiovascular risk prediction in the general population
European Heart Journal · 2007 · https://doi.org/10.1093/eurheartj/ehl448
Regression of Electrocardiographic Left Ventricular Hypertrophy During Antihypertensive Therapy and Reduction in Sudden Cardiac Death
Circulation · 2007 · https://doi.org/10.1161/circulationaha.106.666594
Reduction in Albuminuria Translates to Reduction in Cardiovascular Events in Hypertensive Patients
Hypertension · 2005 · https://doi.org/10.1161/01.hyp.0000154082.72286.2a
Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol
Journal of the American College of Cardiology · 2005 · https://doi.org/10.1016/j.jacc.2004.10.068
Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation
Journal of the American College of Cardiology · 2005 · https://doi.org/10.1016/j.jacc.2004.06.080
N-Terminal Pro Brain Natriuretic Peptide Is Inversely Related to Metabolic Cardiovascular Risk Factors and the Metabolic Syndrome
Hypertension · 2005 · https://doi.org/10.1161/01.hyp.0000179575.13739.72
Does albuminuria predict cardiovascular outcome on treatment with losartan versus atenolol in hypertension with left ventricular hypertrophy? A LIFE substudy
Journal of Hypertension · 2004 · https://doi.org/10.1097/00004872-200409000-00026
Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study
Journal of Hypertension · 2002 · https://doi.org/10.1097/00004872-200209000-00035
Urine albumin/creatinine ratio and echocardiographic left ventricular structure and function in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE study
American Heart Journal · 2002 · https://doi.org/10.1067/mhj.2002.119895
Microalbuminuria in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE Study
Journal of Hypertension · 2002 · https://doi.org/10.1097/00004872-200203000-00015
Current projects
No projects listed.